Two cholesterol drugs better than one for diabetics
NEW YORK (Reuters Health) - Combination therapy with simvastatin and fenofibrate is better than treatment with either drug alone for treating mixed dyslipidemia in patients with type 2 diabetes, according to a report in American Journal of Cardiology.
<p>You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~a/reuters/healthNews?i=uYCvxI" border="0)
</img>
</p><div class="feedflare">
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=MVBCO1F" border="0)
</img>
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=7aJRJKf" border="0)
</img>
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=RwOH5vf" border="0)
</img>
</div>
![](http://feeds.reuters.com/~r/reuters/healthNews/~4/257226549" height="1" width="1)
You are not allowed to view links.
Register or
Login
